Sibenadet hydrochloride is a dual D2 dopamine receptor and β-adrenergic receptor agonist with bronchodilatory activity; it effectively inhibits sensory nerve activity in animal models of chronic obstructive pulmonary disease (COPD), thereby reducing reflex cough, mucus production, and tachypnea.